These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 3583507
21. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL). Phillips NC, Moras ML, Chedid L, Petit JF, Tenu JP, Lederer E, Bernard JM, Lefrancier P. J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756 [Abstract] [Full Text] [Related]
23. In vitro synergic effect of interferon gamma combined with liposomes containing muramyl tripeptide on human monocyte cytotoxicity against fresh allogeneic and autologous tumor cells. Galligioni E, Santarosa M, Favaro D, Spada A, Talamini R, Quaia M. Tumori; 1994 Oct 31; 80(5):385-91. PubMed ID: 7839471 [Abstract] [Full Text] [Related]
26. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Daemen T, Veninga A, Roerdink FH, Scherphof GL. Cancer Res; 1986 Sep 31; 46(9):4330-5. PubMed ID: 3731091 [Abstract] [Full Text] [Related]
30. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes. Saiki I, Sone S, Fogler WE, Kleinerman ES, Lopez-Berestein G, Fidler IJ. Cancer Res; 1985 Dec 31; 45(12 Pt 1):6188-93. PubMed ID: 3933823 [Abstract] [Full Text] [Related]
31. Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma. Kleinerman ES, Maeda M, Jaffe N. Cancer Treat Res; 1993 Dec 31; 62():101-7. PubMed ID: 8096724 [Abstract] [Full Text] [Related]